Found: 9
Select item for more details and to access through your institution.
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 193, doi. 10.1002/ajh.27138
- By:
- Publication type:
- Article
Severe autosomal recessive muscular dystrophy in an extended Sudanese kindred.
- Published in:
- 1983
- By:
- Publication type:
- journal article
One thousand patients with essential thrombocythemia: the Mayo Clinic experience.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00972-x
- By:
- Publication type:
- Article
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00891-x
- By:
- Publication type:
- Article
Congenital glucose-galactose malabsorption in Arab children.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1232, doi. 10.1111/bjh.19325
- By:
- Publication type:
- Article
IDH1/2 inhibitor monotherapy in blast‐phase myeloproliferative neoplasms: A multicentre experience.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 3, p. e87, doi. 10.1111/bjh.19027
- By:
- Publication type:
- Article
ABO blood group type and risk of venous thrombosis in essential thrombocythemia.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 3, p. 699, doi. 10.1111/bjh.18906
- By:
- Publication type:
- Article